KalVista Pharmaceuticals, Inc. Annual Return On Equity in % from 2015 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
KalVista Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2015 to 2023.
  • KalVista Pharmaceuticals, Inc. Return On Equity for the quarter ending July 31, 2024 was -97.4 %, a 60.8% decline year-over-year.
  • KalVista Pharmaceuticals, Inc. annual Return On Equity for 2023 was -77.5 %, a 80.3% decline from 2022.
  • KalVista Pharmaceuticals, Inc. annual Return On Equity for 2022 was -43 %, a 40.6% increase from 2021.
  • KalVista Pharmaceuticals, Inc. annual Return On Equity for 2021 was -72.4 %, a 46% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -77.5 -34.5 -80.3% May 1, 2023 Apr 30, 2024
2022 -43 +29.4 +40.6% May 1, 2022 Apr 30, 2023
2021 -72.4 -22.8 -46% May 1, 2021 Apr 30, 2022
2020 -49.6 -14.7 -42.2% May 1, 2020 Apr 30, 2021
2019 -34.9 +38.4 +52.4% May 1, 2019 Apr 30, 2020
2018 -73.3 -26.8 -57.8% May 1, 2018 Apr 30, 2019
2017 -46.4 -10.4 -28.8% May 1, 2017 Apr 30, 2018
2016 -36.1 +50.9 +58.5% May 1, 2016 Apr 30, 2017
2015 -87 Jan 1, 2015 Dec 31, 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.